Back
Sarepta Therapeutics Vs. MarineMax Industry Stock Comparison
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
114.48
Seasonality Move:
16.38%
Buy
64
HZO
MarineMax
Last Price:
33.41
Seasonality Move:
17.71%
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $114.65. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
MarineMax (HZO)
is a Buy
Is MarineMax a Buy, Sell or Hold?
- The current MarineMax [HZO] share price is $33.39. The Score for HZO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- HZO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $114.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.96 | Sell |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | 573405 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.03 - 128.71) | Sell |
Bollinger Bands (100): | (119.2 - 142.7) | Sell |
HZO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 62.04 | Buy |
Chaikin Money Flow: | 210974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.94 - 31.72) | Buy |
Bollinger Bands (100): | (29.47 - 34.43) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 109.4 | Buy |
20-day SMA: | 117.25 | Sell |
50-day SMA: | 121.8 | Sell |
200-day SMA: | 129.97 | Sell |
8-day EMA: | 112.22 | Buy |
20-day EMA: | 115.74 | Sell |
50-day EMA: | 121.56 | Sell |
200-day EMA: | 125.93 | Sell |
HZO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.15 | Buy |
20-day SMA: | 30.51 | Buy |
50-day SMA: | 31.79 | Buy |
200-day SMA: | 31.02 | Buy |
8-day EMA: | 30.77 | Buy |
20-day EMA: | 30.66 | Buy |
50-day EMA: | 31.1 | Buy |
200-day EMA: | 31.46 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.
MarineMax Earnings Growth & HZO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.10 per share, and an increase next year of $0.17 per share.
Sarepta Therapeutics Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
MarineMax Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |